Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig. 2 H
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR
NF28-29/30 (whole-mount microscopy) |
|
|||||
![]() |
Fig. S 6 D D' D"
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR
NF29/30-31 (immunohistochemistry) |
|
skin disease
|
||||
![]() |
FIg. 2 M
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR
NF40-41 (whole-mount microscopy) |
||||||
![]() |
Fig. 2 I
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR2
NF28-29/30 (whole-mount microscopy) |
|
|||||
![]() |
Fig. S 6 E E' E"
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR2
NF29/30-31 (immunohistochemistry) |
|
skin disease
|
||||
![]() |
Fig. 2 N
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp CRISPR2
NF40-41 (whole-mount microscopy) |
||||||
![]() |
Fig. 6 D
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp MO
NF19-20 (immunohistochemistry) |
|
skin disease
|
||||
![]() |
Fig. 6 I I' I''
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp MO
NF22 (immunohistochemistry) |
|
skin disease
|
||||
![]() |
Fig. 4 B
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp MO
NF26-28 (histology) |
|
skin disease
|
||||
![]() |
Fig. S 3 C D
Bharathan NK and Dickinson AJG (2019) |
Xla Wt + dsp MO
NF26-28 (transmission electron microscopy) |
|
skin disease
|